This approval, together with Eisai's other related products including Warfarin(R) (anticoagulant agent) and Vasolan(R) (calcium antagonistic antiarrthymic treatment which controls increased heart rate in paroxysmal atrial fibrillation/flutter), will enable Eisai to make further contributions to patients by offering treatment options for managing paroxysmal atrial fibrillation/flutter.

The increased heart rate, blood pressure, blood sugar levels, muscle tension, anger, and anxiety are designed to quickly dissipate after an immediate physical threat is over.

The researchers removed individual sheep from the flock for 30-minute stretches and monitored bleating, body movement, increased heart rate, and other signs of stress.